Clinical Trial Update: Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety, efficacy, and pharmacokinetics of CSL889 in adults and adolescents with sickle cell disease during vaso-occlusive cris…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• CSL889

Snippet

Sponsor: CSL Behring | Conditions: Sickle Cell Disease Vaso-occlusive Crisis | Phase 2 | Status: RECRUITING